PTPI (Petros Pharmaceuticals, Inc.) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan Petros Pharmaceuticals, Inc. (PTPI)

Complex patent protections and regulations for transitioning drugs to over-the-counter status create significant barriers to entry in the men's health niche. The GURU.Markets terminal displays the projected price-to-earnings chart for Petros Pharmaceuticals (PTPI), where the current metric is 0.00. Stendra's strong pricing power and the digital transformation of sales ensure stability, although reliance on a single product and marketing limits create operational risks.

petrospharma.com - Rasio kapitalisasi marang bathi mangsa ngarep PTPI (periode 04.07.2022 - 28.06.2025)

Ringkesan rincian data analitis petrospharma.com (PTPI)

- rega saiki lan proyeksi nilai saham:
Produk merek Petros Pharmaceuticals

When screening asset reliability, an investor utilizes the issuer's forward P/E, which determines the share price relative to expected earnings, reflecting market yield expectations. For Petros Pharmaceuticals (PTPI), this metric is critical, as pressure from low-cost generics limits pricing power, necessitating an assessment of branding effectiveness through the trend of forward multiples on the chart.

Analisis pesaing Petros Pharmaceuticals

Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|Amneal - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech Corp - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi glpg.com GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Rasio rega marang bathi sing dikarepake|SPRY - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi TBPH (Theravance Biopharma)|AQST (aquestive.com) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake SCPH (scPharmaceuticals, Inc.)|Prakiraan rega marang bathi TECX|Tonix Pharmaceuticals (TNXP) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SXTC|Pangali Forward P/E Eupraxia Pharma (EPRX)|Rega marang bathi mangsa ngarep BioHarvest Sciences Inc. BHST|EXOZ - Prakiraan rega marang bathi|ORMP: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi abvcpharma.com (ABVC)|Rega marang bathi mangsa ngarep Cumberland Pharma|Rega marang bathi mangsa ngarep QNTM|Pangali Forward P/E FGEN|TELO (Telomir Pharma) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Rani Therapeutics Holdings RANI|SNYR - Prakiraan rega marang bathi|RLYB - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi lexariabioscience.com LEXX|PULM: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep PTHL|Rega marang bathi mangsa ngarep Aptorum Group Limited|LYRA (Lyra Therapeutics, Inc.) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E IBO|Kapitalisasi marang proyeksi bathi TNF Pharmaceuticals, Inc.|Pangali Forward P/E YCBD (cbdMD, Inc.)|PRFX (PainReform Corp) - Rasio rega marang bathi sing dikarepake|CYTO: Prakiraan rega marang bathi|LIPO - Pangali Forward P/E|OptiNose, Inc. (OPTN) - Rega marang bathi mangsa ngarep|PIRS - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Procaps|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP